Vall d'Hebron University Hospital — ERA-LEARN

Skip to content
Skip to footer

Service Navigation

Home
About
Contact
newsalert

Main Menu Search

Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Home
Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

pREdiction of niVOLUmab acTION in metastatic renal cancer patients: Treg function, tumoral access and NK interactions as predictive biomarkers of immunotherapy.

Home
Explore Partnerships
Partnerships
TRANSCAN-2
Joint Transnational Call for Proposals (JTC 2015): Immunology and immunotherapy of Cancer - strengthening the translational aspects
pREdiction of niVOLUmab acTION in metastatic renal cancer patients: Treg function, tumoral access and NK interactions as predictive biomarkers of immunotherapy.
Vall d'Hebron University Hospital

Full name	Vall d'Hebron University Hospital
Short name
Type of organisation
Partner Role	Partner
Country	Spain

Back to project overview

Funded by the European Union under the Grant Agreement no. 101102316. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the granting authority can be held responsible for them.

Sitemap
Imprint
Privacy Policy
Submit accessibility issues
Accessibility Statement

Follow us on LinkedIn

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.